SCHEMBL4182931

SCHEMBL4182931

COC(=O)CCc1cccc(O[Si](C)(C)C(C)(C)C)c1C1CC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
PDE4D Q08499 1/20 0.38
TDP1 Q9NUW8 1/20 0.35
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
PLA2G1B P04054 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
DRD2 P14416 1/20 0.33
CCNC P24863 1/20 0.33
CDK8 P49336 1/20 0.33
TSHR P16473 1/20 0.33
RPS6KB2 Q9UBS0 1/20 0.32
THRA P10827 1/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4183412 0.82 TDP1 (0.38) POLBPDE4DTDP1KDM4EDRD2
SCHEMBL13774982 0.79 PDE4D (0.36) POLBPDE4DTDP1MTNR1AMTNR1B
SCHEMBL4182936 0.78 CA12 (0.36) HPGDALDH1A1HSD17B10DRD2CCNC
SCHEMBL4183409 0.77 IAPP (0.42) POLBPDE4DTDP1MTNR1AMTNR1B
SCHEMBL7242193 0.77 MTNR1A (0.39) POLBMTNR1AMTNR1BALDH1A1SMN1; SMN2
SCHEMBL4184398 0.76 DRD2 (0.36) POLBPDE4DDRD2
SCHEMBL15324144 0.74 MTNR1A (0.52) MTNR1AMTNR1BHPGDALDH1A1DRD2
SCHEMBL27505130 0.72 POLB (0.41) POLBPDE4DTDP1MTNR1AMTNR1B
SCHEMBL27698666 0.71 TDP1 (0.43) POLBPDE4DTDP1MTNR1AMTNR1B
SCHEMBL4183160 0.71 DRD2 (0.47) KDM4EHPGDALDH1A1SMN1; SMN2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192203-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2009-07-30 US disclosed
US-20090192203-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2009-07-30 US disclosed
US-20080292608-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2008-11-27 US disclosed
US-20080292608-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2008-11-27 US disclosed
EP-1945620-A2 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2008-07-23 EP disclosed
EP-1945633-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2008-07-23 EP disclosed
WO-2007056366-A2 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-05-18 WO disclosed
WO-2007056497-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080292608-A1 Compounds and Compositions as Ppar Modulators PPARG, PPARA, PPARD POLB 950/4885PDE4D 1157/4885TDP1 3284/4885
US-20090192203-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS PPARG, PPARA, PPARD POLB 950/4885PDE4D 1157/4885TDP1 3284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.